Skip to content

The FDA Warns Consumers About Apetamin — Here’s Why

Apetamin often comes in the form of a syryp.

The US Food and Drug Administration (FDA) recently warned the public about online sales of Apetamin — an unapproved drug produced internationally and sold worldwide. Read more to understand why this drug is potentially harmful to consumers. Then, download the Top 10 High-Risk Trends That Put You At Risk of Card Brand Fines for more information about repackaged Apetamin and other problematic products that put you at risk.

 

The FDA Warns Consumers About Adverse Events Associated With Apetamin

Recently, the US Food and Drug Administration (FDA) released a warning to consumers about adverse effects associated with Apetamin — an unregulated drug illegally sold in the United States via online channels.

The FDA’s Adverse Event Reporting System dashboard ensures the public can view all adverse event reports filed by the pharmaceutical industry, professionals who work with said pharmaceuticals, and consumers. The FDA uses the data in this system to evaluate drugs for safety and efficacy.

 

What Exactly Is Apetamin?

Apetamin contains the antihistamine cyproheptadine, which increases appetite. This helps consumers achieve their desired weight gain — but with potentially harmful side effects.

Apetamin is manufactured internationally and is typically sold online via social media advertisements, illicit websites, and in some brick-and-mortar stores. The FDA has put safeguards in place to restrict importation and issued a warning to consumers.

What are the Adverse Effects of Apetamin?

The FDA’s warning was based on several research studies and cases of adverse effects in those who consistently used Apetamin on a regular basis for a set period of time.

According to the FDA, Apetamin is known to include symptoms including but not limited to:

  • Decreased mental alertness
  • Decreased motor coordination (such as the ability to operate a motor vehicle)
  • Hallucinations
  • Convulsions
  • Decreased breath and heart rates
  • Rash
  • Low blood pressure
  • Anemia
  • Frequent urination
  • Dryness or soreness of the throat
  • Headache
  • Coma
  • Death

 

Learn More When You Download This Guide

Are you concerned that online sales of unapproved drugs could result in hefty card brand fines or damage your reputation? Read our 36-page guide illuminating the Top 10 High-Risk Trends That Put You At Risk of Card Brand Fines.

In the guide, you can explore some of the most pervasive online trends, including:

  • Novel cannabinoids
  • Merchant clusters
  • And repackaged Apetamin

 

Smelting words into a specialty since 2020, Thea Le Fevre specializes in B2B SaaS Content Marketing. Take a deep dive into her work for up-to-date industry news surrounding issues in payments risk & compliance, trust & safety, regulatory compliance, and more.

Recent Blog Articles

Social Casinos: The Free-to-Play Trap

Many online casinos have adapted their business model to offer free-to-play sweepstakes to avoid gambling regulations, creating a gateway for young audiences to enter the world of betting. Governments and payment providers alike face challenges as they navigate shifting laws. LegitScript helps keep...

Why LegitScript Certification Is Your Passport in 2025: A Recap for Healthcare Businesses

In a dynamic regulatory landscape where risk, reputation, and compliance increasingly determine access to financial services, healthcare businesses face a unique challenge. A recent webinar hosted by LegitScript - featuring Rob Bast, chief sales officer at Corepay, and Angela Salter, director of sal...

LegitScript & Special Guest Marketplace Risk Panel Recap: How to Stay Ahead of Global Regulations and Trends: Using Deep Intelligence to Shape Policy and Mitigate Risk

At Marketplace Risk, experts tackled the challenges of content moderation and platform responsibility, focusing on drug-related content, evolving evasion tactics, and the balance between AI and human oversight. Transparency and proactive safety measures took center stage. Listen below to an excerpt...
FDA updates REMS program for common abortion drug mifepristone.

Key Takeaways from LegitScript’s Webinar: Navigating Risks and Regulations in Online Abortion Pill Sales

The online sale of abortion medication is at the center of a rapidly evolving regulatory and risk environment. In LegitScript's June 2025 webinar, Online Abortion Pill Sales: Navigating Regulations and Problematic Activity, experts outlined how recent legal changes are reshaping access to medication...